secwatch.observer — SEC 8-K summary
======================================

Issuer:     IO Biotech, Inc. (IOBTQ)
CIK:        0001865494
Form:       8-K
Filed at:   2025-12-19T23:59:59+00:00
Accession:  0001193125-25-327089
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

IO Biotech receives Nasdaq bid price deficiency notice; has until June 16, 2026 to regain compliance
--------------------------------------------------------------------------------

- Nasdaq notified IO Biotech on Dec 17, 2025 that bid price < $1.00 for 30 consecutive days.
- Company has 180 calendar days, until June 16, 2026, to regain compliance.
- To comply, closing bid price must be >= $1.00 for at least 10 consecutive trading days.
- If not compliant by June 2026, may apply for a second 180-day period by transferring to Nasdaq Capital Market.
- No immediate effect on listing; stock continues trading on Nasdaq Global Select Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1865494/000119312525327089/0001193125-25-327089-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1865494/000119312525327089/d71494d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-327089

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer